Conversely, LA has been shown to augment PIEZO2 activity [95], suggesting a potential strategy for targeting malignancies characterized by PIEZO2 deficiency, such as NSCLC. This evidence concerns the gene PIEZO2 and non-small cell lung carcinoma.